Development and Evaluation of a Fertility Preservation Patient Decision Aid for Women With Cancer.
NCT02753296 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 98
Last updated 2016-04-27
Summary
The aim of this research study is to develop a patient decision aid (PDA), and evaluate whether its integration within oncology services enable cancer services to effectively support and provide evidence based resources for women's fertility preservation decisions, following a diagnosis of any cancer type.
Conditions
Sponsors & Collaborators
-
Yorkshire Cancer Research
collaborator OTHER -
Weston Park Hospital Cancer Charity
collaborator OTHER -
Sheffield Teaching Hospitals NHS Foundation Trust
collaborator OTHER -
Sheffield Hallam University
collaborator OTHER -
University of Leeds
collaborator OTHER -
The Leeds Teaching Hospitals NHS Trust
collaborator OTHER -
Breast Cancer Care (Charity)
collaborator UNKNOWN -
Independent Cancer Patients' Voice (Charity)
collaborator UNKNOWN -
University of Oxford
collaborator OTHER -
University of Sheffield
lead OTHER
Principal Investigators
-
Georgina L Jones, D.Phil · Sheffield University
Eligibility
- Min Age
- 16 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-05-31
- Primary Completion
- 2018-06-30
- Completion
- 2018-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Oxford Ovarian Cancer Predict Chemotherapy Response 01
NCT01770535 ·Status: UNKNOWN
-
Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
NCT01372787 ·Status: UNKNOWN
-
Ovarian Reserve After Cancer: Longitudinal Effects
NCT02467231 ·Status: ACTIVE_NOT_RECRUITING
-
The Longitudinal Ovarian Reserve Study
NCT02395341 ·Status: COMPLETED
-
Primary Tumor Harvest for the Purpose of Possible Use in a Future Clinical Trial in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer
NCT00801320 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Chemotherapy Influence on Clinical and Biological Markers of Ovarian Reserve
NCT00712452 ·Status: TERMINATED ·Phase: NA
-
Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer
NCT00230542 ·Status: COMPLETED ·Phase: PHASE2
-
Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer
NCT06360471 ·Status: RECRUITING
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Reproductive Health Survivorship Care Plan
NCT02667626 ·Status: COMPLETED ·Phase: NA
-
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT01962948 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260 ·Status: COMPLETED
-
Survival Outcomes of Ovarian Malignancies in Chinese Population
NCT03291262 ·Status: UNKNOWN
-
Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers
NCT02412124 ·Status: TERMINATED ·Phase: NA
-
Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction
NCT01083537 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca
NCT00787488 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Gonadotoxic Therapies on Fertility
NCT05885048 ·Status: RECRUITING
-
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT00719303 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Genes and the Environment in Patients With Ovarian Cancer in the East Anglia, Oxford, Trent, or West Midlands Regions of the United Kingdom
NCT00757263 ·Status: UNKNOWN
-
Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas
NCT00750386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessment of Ovarian Reserve in Female Cancer Survivors
NCT01062542 ·Status: COMPLETED
-
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
NCT06312124 ·Status: RECRUITING ·Phase: NA
-
An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemotherapy
NCT00191646 ·Status: COMPLETED ·Phase: PHASE3
-
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
NCT06304922 ·Status: NOT_YET_RECRUITING
-
Patient Reported Symptoms in Ovarian Cancer (PRECISION)
NCT01422265 ·Status: COMPLETED